Literature DB >> 23228615

Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism.

Anwesha Banerjee1, Francisco García-Oscos, Swagata Roychowdhury, Luis C Galindo, Shawn Hall, Michael P Kilgard, Marco Atzori.   

Abstract

The biological mechanisms of autism spectrum disorders (ASDs) are largely unknown in spite of extensive research. ASD is characterized by altered function of multiple brain areas including the temporal cortex and by an increased synaptic excitation:inhibition ratio. While numerous studies searched for evidence of increased excitation in ASD, fewer have investigated the possibility of reduced inhibition. We characterized the cortical γ-amino butyric acid (GABA)ergic system in the rat temporal cortex of an ASD model [offspring of mothers prenatally injected with valproic acid (VPA)], by monitoring inhibitory post-synaptic currents (IPSCs) with patch-clamp. We found that numerous features of inhibition were severely altered in VPA animals compared to controls. Among them were the frequency of miniature IPSCs, the rise time and decay time of electrically-evoked IPSCs, the slope and saturation of their input/output curves, as well as their modulation by adrenergic and muscarinic agonists and by the synaptic GABAA receptor allosteric modulator zolpidem (but not by the extra-synaptic modulator gaboxadol). Our data suggest that both pre- and post-synaptic, but not extra-synaptic, inhibitory transmission is impaired in the offspring of VPA-injected mothers. We speculate that impairment in the GABAergic system critically contributes to an increase in the ratio between synaptic excitation and inhibition, which in genetically predisposed individuals may alter cortical circuits responsible for emotional, communication and social impairments at the core of ASD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23228615      PMCID: PMC3674140          DOI: 10.1017/S1461145712001216

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  73 in total

Review 1.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

Review 2.  Short-term synaptic plasticity.

Authors:  Robert S Zucker; Wade G Regehr
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

Review 3.  Catatonia: clinical aspects and neurobiological correlates.

Authors:  Jessica Daniels
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

4.  Fetal valproate syndrome and autism: additional evidence of an association.

Authors:  G Williams; J King; M Cunningham; M Stephan; B Kerr; J H Hersh
Journal:  Dev Med Child Neurol       Date:  2001-03       Impact factor: 5.449

5.  Reduced acetylcholinesterase activity in the fusiform gyrus in adults with autism spectrum disorders.

Authors:  Katsuaki Suzuki; Genichi Sugihara; Yasuomi Ouchi; Kazuhiko Nakamura; Masatsugu Tsujii; Masami Futatsubashi; Yasuhide Iwata; Kenji J Tsuchiya; Kaori Matsumoto; Kiyokazu Takebayashi; Tomoyasu Wakuda; Yujiro Yoshihara; Shiro Suda; Mitsuru Kikuchi; Nori Takei; Toshirou Sugiyama; Toshiaki Irie; Norio Mori
Journal:  Arch Gen Psychiatry       Date:  2011-03

6.  Use of clonidine in children with autism spectrum disorders.

Authors:  Xue Ming; Emily Gordon; Ning Kang; George C Wagner
Journal:  Brain Dev       Date:  2008-02-15       Impact factor: 1.961

7.  Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.

Authors:  Tomasz Schneider; Ryszard Przewłocki
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

Review 8.  Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability.

Authors:  Mihir S Parikh; Alexander Kolevzon; Eric Hollander
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-04       Impact factor: 2.576

9.  Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid.

Authors:  Tomasz Schneider; Adam Roman; Agnieszka Basta-Kaim; Marta Kubera; Bogusława Budziszewska; Karolina Schneider; Ryszard Przewłocki
Journal:  Psychoneuroendocrinology       Date:  2008-04-08       Impact factor: 4.905

10.  Neocortical excitation/inhibition balance in information processing and social dysfunction.

Authors:  Ofer Yizhar; Lief E Fenno; Matthias Prigge; Franziska Schneider; Thomas J Davidson; Daniel J O'Shea; Vikaas S Sohal; Inbal Goshen; Joel Finkelstein; Jeanne T Paz; Katja Stehfest; Roman Fudim; Charu Ramakrishnan; John R Huguenard; Peter Hegemann; Karl Deisseroth
Journal:  Nature       Date:  2011-07-27       Impact factor: 49.962

View more
  41 in total

1.  In utero exposure to valproic acid disrupts ascending projections to the central nucleus of the inferior colliculus from the auditory brainstem.

Authors:  Ryan Zimmerman; Amanda Smith; Tatiana Fech; Yusra Mansour; Randy J Kulesza
Journal:  Exp Brain Res       Date:  2020-01-25       Impact factor: 1.972

2.  Degraded auditory processing in a rat model of autism limits the speech representation in non-primary auditory cortex.

Authors:  C T Engineer; T M Centanni; K W Im; M S Borland; N A Moreno; R S Carraway; L G Wilson; M P Kilgard
Journal:  Dev Neurobiol       Date:  2014-04-04       Impact factor: 3.964

3.  Vagal nerve stimulation blocks interleukin 6-dependent synaptic hyperexcitability induced by lipopolysaccharide-induced acute stress in the rodent prefrontal cortex.

Authors:  Francisco Garcia-Oscos; David Peña; Mohammad Housini; Derek Cheng; Diego Lopez; Michael S Borland; Roberto Salgado-Delgado; Humberto Salgado; Santosh D'Mello; Michael P Kilgard; Stefan Rose-John; Marco Atzori
Journal:  Brain Behav Immun       Date:  2014-08-13       Impact factor: 7.217

4.  Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial.

Authors:  Seyedeh-Mahsa Mahdavinasab; Amene Saghazadeh; Nogol Motamed-Gorji; Salar Vaseghi; Mohammad-Reza Mohammadi; Rosa Alichani; Shahin Akhondzadeh
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-04-12       Impact factor: 4.785

5.  Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autism.

Authors:  Julie Le Merrer; Jerome A J Becker; Cécile Derieux; Audrey Léauté; Agathe Brugoux; Déborah Jaccaz; Claire Terrier; Jean-Philippe Pin; Julie Kniazeff
Journal:  Neuropsychopharmacology       Date:  2022-04-13       Impact factor: 8.294

6.  Maternal Exposure to Valproic Acid Primarily Targets Interneurons Followed by Late Effects on Neurogenesis in the Hippocampal Dentate Gyrus in Rat Offspring.

Authors:  Yousuke Watanabe; Tomoaki Murakami; Masashi Kawashima; Yasuko Hasegawa-Baba; Sayaka Mizukami; Nobuya Imatanaka; Yumi Akahori; Toshinori Yoshida; Makoto Shibutani
Journal:  Neurotox Res       Date:  2016-08-26       Impact factor: 3.911

7.  Analysis of Extracellular Nucleotide Metabolism in Adult Zebrafish After Embryological Exposure to Valproic Acid.

Authors:  Fernanda Francine Zimmermann; Karina Vidarte Gaspary; Anna Maria Siebel; Carlos Eduardo Leite; Luiza Wilges Kist; Mauricio Reis Bogo; Carla Denise Bonan
Journal:  Mol Neurobiol       Date:  2016-05-17       Impact factor: 5.590

Review 8.  Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies.

Authors:  Natascia Brondino; Laura Fusar-Poli; Cristina Panisi; Stefano Damiani; Francesco Barale; Pierluigi Politi
Journal:  J Autism Dev Disord       Date:  2016-03

9.  Association of Autism Spectrum Disorder With Prenatal Exposure to Medication Affecting Neurotransmitter Systems.

Authors:  Magdalena Janecka; Arad Kodesh; Stephen Z Levine; Shari I Lusskin; Alexander Viktorin; Rayees Rahman; Joseph D Buxbaum; Avner Schlessinger; Sven Sandin; Abraham Reichenberg
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

10.  Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism.

Authors:  S Hossein Fatemi; Teri J Reutiman; Timothy D Folsom; Oyvind G Rustan; Robert J Rooney; Paul D Thuras
Journal:  J Autism Dev Disord       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.